Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.
Deuschl C, Moenninghoff C, Goericke S, Kirchner J, Köppen S, Binse I, Poeppel TD, Quick HH, Forsting M, Umutlu L, Herrmann K, Hense J, Schlamann M.
Deuschl C, et al. Among authors: kirchner j.
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1285-1295. doi: 10.1007/s00259-017-3661-0. Epub 2017 Mar 3.
Eur J Nucl Med Mol Imaging. 2017.
PMID: 28258444